NCT01131130

Brief Summary

The objective of this study is to determine the product feasibility of the investigational contact lens (Test) when compared to the currently marketed Acuvue Oasys contact lens (Control) and the Air Optix Aqua contact lens (Control) when worn by adapted wearers of soft contact lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

May 25, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 26, 2010

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
3.9 years until next milestone

Results Posted

Study results publicly available

April 30, 2014

Completed
Last Updated

April 30, 2014

Status Verified

March 1, 2014

Enrollment Period

1 month

First QC Date

May 25, 2010

Results QC Date

March 28, 2014

Last Update Submit

March 28, 2014

Conditions

Keywords

Contact lens

Outcome Measures

Primary Outcomes (2)

  • Comfort Throughout the Day - Test Lens vs. Air Optix Aqua Lens

    Subjective measurements of lens comfort were rated on a scale from 0 to 100, where 100 was the most favorable.

    7 days

  • Comfort Throughout the Day - Test Lens vs. Acuvue Oasys

    Subjective measurements of lens comfort were rated on a scale from 0 to 100, where 100 was the most favorable.

    7 days

Secondary Outcomes (2)

  • Lens Wettability, Test Lens vs. Acuvue Oasys

    7 days

  • Lens Wettability, Test Lens vs. Air Optix Aqua

    7 days

Study Arms (3)

Investigational contact lens

EXPERIMENTAL

Bausch \& Lomb

Device: Investigational contact lens

Acuvue Oasys Contact Lens

ACTIVE COMPARATOR

Johnson \& Johnson Lens

Device: Acuvue Oasys Contact Lens

Air Optix Aqua

ACTIVE COMPARATOR

Ciba Vision

Device: Air Optix Aqua

Interventions

After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.

Investigational contact lens

After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.

Acuvue Oasys Contact Lens

After one week of wearing the first lens type, the participants will crossover to the second lens type for one week, and then crossover to the third lens type.

Air Optix Aqua

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants must have clear central corneas and be free of any anterior segment disorders.
  • Participants must be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
  • Participants must be myopic and require lens correction from -0.75 D to - 4.75D in each eye.

You may not qualify if:

  • Participants who have worn gas permeable (GP) contact lenses within the last 30 days or who have worn polymethylmethacrylate (PMMA) lenses within the last three months.
  • Participants with any systemic disease affecting ocular health.
  • Participants using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
  • Participants with an active ocular disease or are using any ocular medication.
  • Participants who have had any corneal surgery (eg, refractive surgery).
  • Participants who are allergic to any component in the study care products.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bausch & Lomb

Rochester, New York, 14609, United States

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Dr. Robert Steffen
Organization
Bausch + Lomb

Study Officials

  • Gerard Carains, MCOptom, PhD

    Bausch & Lomb Incorporated

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2010

First Posted

May 26, 2010

Study Start

May 1, 2010

Primary Completion

June 1, 2010

Study Completion

June 1, 2010

Last Updated

April 30, 2014

Results First Posted

April 30, 2014

Record last verified: 2014-03

Locations